Regeneron Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 223 U.S.-traded ETFs. REGN has around 11.2M shares in the U.S. ETF market. The largest ETF holder of REGN is the Invesco QQQ Trust (QQQ), with approximately 1.32M shares. Investors may also find of interest that the ETF with the largest allocation to REGN stock is ARK Genomic Revolution ETF (ARKG), with a portfolio weight of 5.34%. On average, U.S. ETFs allocate 0.65% of REGN to their portfolios.
Additionally, REGN is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with REGN as a holding is the iShares Morningstar U.S. Equity ETF (ILCB), with a return of 498.40%.